EFFICACY TRIALS OF AIDS VACCINES - HOW SCIENCE CAN INFORM ETHICS - GUEST EDITORIAL

被引：8
作者：
FAST, PE
MATHIESON, BJ
SCHULTZ, AM
机构：
[1] National Institute of Allergy and Infectious Diseases, Bethesda
来源：
CURRENT OPINION IN IMMUNOLOGY | 1994年 / 6卷 / 05期
关键词：
D O I：
10.1016/0952-7915(94)90070-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：691 / 697
页数：7
相关论文
共 70 条
  • [31] GRADY C, 1994, THESIS GEORGETOWN U
  • [32] Graham B S, 1990, Infect Dis Clin North Am, V4, P223
  • [33] VACCINATION OF VACCINIA-NAIVE ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP160 RECOMBINANT VACCINIA VIRUS IN A BLINDED, CONTROLLED, RANDOMIZED CLINICAL-TRIAL
    GRAHAM, BS
    BELSHE, RB
    CLEMENTS, ML
    DOLIN, R
    COREY, L
    WRIGHT, PF
    GORSE, GJ
    MIDTHUN, K
    KEEFER, MC
    ROBERTS, NJ
    SCHWARTZ, DH
    AGOSTI, JM
    FERNIE, BF
    STABLEIN, DM
    MONTEFIORI, DC
    LAMBERT, JS
    HU, SL
    ESTERLITZ, JR
    LAWRENCE, DN
    KOFF, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) : 244 - 252
  • [34] AUGMENTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING ANTIBODY BY PRIMING WITH GP160 RECOMBINANT VACCINIA AND BOOSTING WITH RGP160 IN VACCINIA-NAIVE ADULTS
    GRAHAM, BS
    MATTHEWS, TJ
    BELSHE, RB
    CLEMENTS, ML
    DOLIN, R
    WRIGHT, PF
    GORSE, GJ
    SCHWARTZ, DH
    KEEFER, MC
    BOLOGNESI, DP
    COREY, L
    STABLEIN, DM
    ESTERLITZ, JR
    HU, SL
    SMITH, GE
    FAST, PE
    KOFF, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) : 533 - 537
  • [35] COMPARATIVE CLONAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CD4+ AND CD8+ CYTOLYTIC LYMPHOCYTES-T ISOLATED FROM SERONEGATIVE HUMANS IMMUNIZED WITH CANDIDATE HIV-1 VACCINES
    HAMMOND, SA
    BOLLINGER, RC
    STANHOPE, PE
    QUINN, TC
    SCHWARTZ, D
    CLEMENTS, ML
    SILICIANO, RF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) : 1531 - 1542
  • [36] HANSON C, 1994, AIDS RES HUM RETROV, V10, P644
  • [37] SCIENTIFIC AND SOCIAL-ISSUES OF HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE DEVELOPMENT
    HAYNES, BF
    [J]. SCIENCE, 1993, 260 (5112) : 1279 - 1286
  • [38] THE PRINCIPAL NEUTRALIZATION DETERMINANT OF SIMIAN IMMUNODEFICIENCY VIRUS DIFFERS FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    JAVAHERIAN, K
    LANGLOIS, AJ
    SCHMIDT, S
    KAUFMANN, M
    CATES, N
    LANGEDIJK, JPM
    MELOEN, RH
    DESROSIERS, RC
    BURNS, DPW
    BOLOGNESI, DP
    LAROSA, GJ
    PUTNEY, SD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) : 1418 - 1422
  • [39] JOHNSTON M, 1993, AIDS RES HUM RETROV, V9, pS117
  • [40] A PHASE-I STUDY OF HGP-30, A 30 AMINO-ACID SUBUNIT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17 SYNTHETIC PEPTIDE ANALOG SUBUNIT VACCINE IN SERONEGATIVE SUBJECTS
    KAHN, JO
    STITES, DP
    SCILLIAN, J
    MURCAR, N
    STRYKER, R
    VOLBERDING, PA
    NAYLOR, PH
    GOLDSTEIN, AL
    SARIN, PS
    SIMMON, VF
    WANG, SS
    HESELTINE, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) : 1321 - 1325
1234567